chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a physician refers to a patient of unknown age. On 20-MAY-2013, the patient was vaccinated with an expired dose of PNEUMOVAX23 (lot # 672074/1502AA, expiry date 19-MAY-2013. Concomitant medications were not reported. No symptoms were reported. Additional information has been requested.
2 days after the vaccination, patient developed pain behind left ear. She was seen by the MD and suggested to take Tylenol, which helps relieve the pain but then it would come back again. Pain and sensitivity on left side around ear still persists until today, being a little better now.
Severe body aches - esp back pain;  Stomach pain, nausea and vomiting; brain fog, chills, fever
Received the second dose of the vaccine on Friday 19Apr2019 and developed significant muscle and joint pain, nausea on 20Apr2019 and a golf ball size lymph node enlargement above my left clavicle that wore very red and tender on 21Apr2019.
patient stated he had chills and a high temp that evening (102-103). woke up feeling a little better. saw dr that day and had a phone conversation. he is also following up with dr this week
After she got the vaccine, she felt dizzy, nauseated and about to faint, her finger was rigid and unable to extend on her left hand (where she got her vaccines on)
The Thursday after the 2nd dose I began experiencing severe shortness of breath and almost fainted.  I called my doctor immediately and she advised that these are normal reactions to the vaccine. I began experiencing heart palpitations followed by not being able to breathe.
This spontaneous report as received from a Licensed practical Nurse refers to an unspecified number of patients. On an unknown date the patients were vaccinated with RECOMBIVAX HB (dose, route and lot were not provided). Other suspect therapies included VAQTA (dose, route and lot were not provided) and PEDVAXHIB (dose, route and lot were not provided). On an unspecified date, the vaccines were exposed to 31 F for 15 hours and also 33 F for 4 days, which is an excursion that is unsupported by in-house stability data. No adverse events symptoms were reported. All telephone attempts to obtain follow up information have been unsuccessful. Additional information has been requested.
One week after, I had redness, swelling, and itching at the injection site. I also have had 2 bouts of severe, sudden, and painful gas with softened stool.  The redness is spreading to a palm size on my arm.
Mild fever.  Headache.  General body achiness.  Tired and lethargic.    Last 24-36 hours.  Then totally cleared up.
10/16/2003: Awakened 06:30-red band around shoulder-in afternoon, redness (deep red) to right side of chest.  Saw MD 15:00 10/16/2003.  Did not receive any prescription.  10/17/2003, redness increased to left side of chest.  Up to arm pit.  Stopped to see nurse in MD office-she suggested taking Benadryl 1 tab every 4-6 hours.  No improvement at this time 15:45, 10/17/2003.
This spontaneous report as received from a Licensed Practical Nurse regarding an unspecified number of patients of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date, the patients were vaccinated with improperly stored GARDASIL. No adverse event was reported. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
I am not quite sure when this started, but I believe it began two or three days after receiving the shot. Today would be day 9 since I have had the first dose. I have been experiencing a brain fog and strange head pressure (not painful, just somewhat uncomfortable), as well as slight dizziness and hard to focus. I previously had Covid on 12/21/2020. It seems to come and go throughout the day. Some days are more foggy than others.
Appetite curtailed; Dizzy; Fatigue; Sweats; Upset stomach; Aches; Chills; Nauseas; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweats), ABDOMINAL DISCOMFORT (Upset stomach), DECREASED APPETITE (Appetite curtailed), DIZZINESS (Dizzy) and PAIN (Aches) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced HYPERHIDROSIS (Sweats), ABDOMINAL DISCOMFORT (Upset stomach), PAIN (Aches), CHILLS (Chills), NAUSEA (Nauseas) and MYALGIA (Muscle aches). On 20-Feb-2021, the patient experienced DECREASED APPETITE (Appetite curtailed), DIZZINESS (Dizzy) and FATIGUE (Fatigue). On 20-Feb-2021, HYPERHIDROSIS (Sweats), DECREASED APPETITE (Appetite curtailed), DIZZINESS (Dizzy), PAIN (Aches), CHILLS (Chills), NAUSEA (Nauseas) and MYALGIA (Muscle aches) had resolved. On 21-Feb-2021, FATIGUE (Fatigue) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (Upset stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-09400 (Patient Link).
Hives all over the body; Arm is swollen; Hurts badly; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives all over the body), PERIPHERAL SWELLING (Arm is swollen) and PAIN IN EXTREMITY (Hurts badly) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives all over the body), PERIPHERAL SWELLING (Arm is swollen) and PAIN IN EXTREMITY (Hurts badly). The patient was treated with TRIAMCINOLONE (topical) for Hives, at a dose of 1 percent. At the time of the report, URTICARIA (Hives all over the body) had not resolved and PERIPHERAL SWELLING (Arm is swollen) and PAIN IN EXTREMITY (Hurts badly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Live follow up received on 11-Jun-2021 and contains updated event outcome to not recovered
Excessice, unquenchable thirst, dry mouth, tingling tongue from 3/23 afternoon to 3/27. Level of thirst was severe enough to interfere with sleep and work. Felt slight tongue tingling sensation 15 min after vaccine, but went away until the next day.
Information has been received from a registered nurse concerning a male who was vaccinated with a dose of VAQTA.  On that same day, the patient experienced neurological symptoms.  The patient contacted the nurse for medical attention.  The outcome was unknown.  There was no product quality complaint.  This is one of two reports from the same patient.  Additional information has been requested.
Patient received her dose and began to feel wheezy, dizzy, clammy and sweating about 10 minutes later. She was sitting and looking very pale. Her parents gave her a smoothie to drink. We elevated her legs up on another chair. Her blood pressure was taken and was very low 75/56 pulse of 60. She stated she was starting to feel better after sitting down after a few minutes, and relaxing and drinking fluids. We checked her blood pressure again about 10 minutes later and it had increased to 85/76 pulse of 78. She stated feeling much better. Parents were asked if they wanted to call rescue to evaluate her. But she refused, stating she was feeling better and recuperating. She decided to walk around the store with her parent for a bit before leaving, stating she was feeling much better.
Her arm was a little sore; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (tradename unspecified, lot number was unknown) solution for injection in pre-filled syringe, via an unspecified route of administration on an unspecified date at a single dose for pneumonia. Medical history included atrial fibrillation. Concomitant medications include heart medication every day and unspecified vitamins. The patient experienced her arm was a little sore on an unspecified date. Outcome of the events was unknown.    Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) has submitted the same report to the regulatory authorities.  No follow-up attempts are needed. No further information is expected.
Fever Incredible body aches  Headache  Sore throat  Arm tenderness where I got the shot
Felt terrible; Body ache; Headache; Joint ache; Fatigue; 101 degree fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (101 degree fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Codeine), Penicillin allergy and Osteoporosis (Condition has improved and have reclast infusions annually.) since 2000. Concomitant products included IBUPROFEN (ADVIL 12 HOUR) from 20-Jan-2021 to 30-Jan-2021 for Back pain.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021 at 8:30 AM, the patient experienced PYREXIA (101 degree fever). On 08-Mar-2021 at 8:00 PM, PYREXIA (101 degree fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 101 (Inconclusive) 101 degree.         No treatment information was provided. Action taken with mRNA-1273 in response to the events were not applicable.
Light-headed; Slight headache; Soreness in scalp on his head / When he presses on the surface of his head it is sore in a couple of spots; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 66 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Feb2021 (Lot number: EN6203) at the age of 66 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "retreatment of root canal", start date: Feb2021 (unspecified if ongoing), notes: performed a couple of days before first dose of Pfizer COVID-19 Vaccine administered.; "infection in mouth due to root canal", start date: Feb2021 (unspecified if ongoing); "aches and pains" (unspecified if ongoing); "shingles" (unspecified if ongoing), notes: had it 20 years ago; "sharp pain in the back, which was isolated pain" (unspecified if ongoing); "wasn't able to sleep" (unspecified if ongoing). Concomitant medication(s) included: AMOXICILLIN taken for oral infection, start date: 28Feb2021, stop date: 07Mar2021. Vaccination history included: Shingles vaccine, for immunisation, reaction(s): "felt pretty crummy". The following information was reported: DIZZINESS (non-serious), outcome "recovered", described as "Light-headed"; HEADACHE (non-serious), outcome "recovered", described as "Slight headache"; PAIN OF SKIN (non-serious), outcome "not recovered", described as "Soreness in scalp on his head / When he presses on the surface of his head it is sore in a couple of spots". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a from pharmacy technician concerning a currently 14 months old child. Gender was not reported. Medical history and concurrent conditions were not reported. On 10-MAR-2014, the patient was vaccinated with VARIVAX lot #J007955; expiration date: 27-JUN-2015, (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Patient was vaccinated with VARIVAX that was exposed to 43.1 degrees F for 29 hours on 03-MAR-2014. This is one of several reports from the same reporter. Additional information has been requested.
Feeling numbness in nose; numbness in forehead; This is a spontaneous report was received from a contactable consumer or other non hcp (patient's mother). A 12-years-old female patient of weight 40.816 kilograms and height 147 centimetres received bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EW0175; Expiration Date: 31Aug2021), via an unspecified route of administration on 23May2021 as 1st dose, single dose for covid-19 immunisation. The patient's medical history was not reported. Concomitant medication included vitamin D no's (VITAMIN D) and elderberries. The patient's mother reported that her daughter who was 12 she had COVID Vaccine on Sunday and on 24May2021, she was feeling numbness in her nose. She felt numbness in her forehead but that went away, but her nose was still numb. She knew she read through the symptoms and that was not one of them, so she was just wondering if it was like allergic reactions or was that part of the symptoms. The patient was treated with Tylenol and Ibuprofen. The patient is going to get the second dose of vaccination on 13Jun2021. On an unspecified date in 2021, the patient had recovered from numbness on the forehead and was not recovered from numbness on the nose.   Information on Lot/Batch number was available. Additional information has been requested.   Follow-up attempts are possible. Further information is expected.
Possible intussusception. Abdominal pain/blood in stool. Abnormal x-ray. Resolved on own.
Increased  genital herpes outbreaks.  Extreme increase in genital herpes outbreaks.   High White Blood Count - Infection, vertigo and extreme dizziness.
fever was just under 103 and close to 105; severe fatigue; muscle soreness; horrible chills through the night; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EM9809), via an unspecified route of administration in the arm right on 09Feb2021 15:45 as dose 2 single (at the age of 42-years-old) for covid-19 immunization. Medical history included mitochondrial mutation, hashimotos thyroiditis (mild-no medication) and allergy to cucumbers (mild allergy). The concomitant medications included multivitamin and Vitamin D gummies. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EL3302), via an unspecified route of administration in the arm right on 19Jan2021 13:30 PM as dose 1 single (at the age of 42-years-old) for covid-19 immunization. The day patient got second dose, she felt good. On 10Feb2021 01:15 AM, during the night patient could not sleep because she had horrible chills through the night. By the next morning fever was just under 103. The patient had severe fatigue and muscle soreness. Fever kept going up, and at times was registering close to 105. The patient took acetaminophen and ibuprofen alternated before could get fever down. Patient fever broke during the following night, and she was okay the following day. The high fever did scare her a little. Patient did not regret getting the vaccine, but the high fever did scare her. Therapeutic measures were not taken for the events chills, fatigue and myalgia. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have covid prior to vaccination and patient did not tested for covid post vaccination. The outcome of the event was recovered.  Follow-up attempts completed. No further information expected.
Expired vaccine was given to the patient; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine was given to the patient) and NO ADVERSE EVENT (no adverse event) in an adult female patient who received mRNA-1273 (Spikevax) (batch no. 015B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine was given to the patient) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine was given to the patient) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine was given to the patient).    No concomitant medications was reported.  It was reported that the 6 doses monovalent vaccines vial size of 5 ml was initially stored in refrigerator on 16-Feb-2023 and was administered to patients on 24-Feb-2023, 28-Feb-2023, 01-Mar-2023 and 06-Mar-2023. The vial did not undergone any temperature excursions.  No treatment medications was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-715780, US-MODERNATX, INC.-MOD-2023-715730, US-MODERNATX, INC.-MOD-2023-715785, US-MODERNATX, INC.-MOD-2023-715804, US-MODERNATX, INC.-MOD-2023-715806 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-715730: US-MODERNATX, INC.-MOD-2023-715785: US-MODERNATX, INC.-MOD-2023-715780: US-MODERNATX, INC.-MOD-2023-715804: US-MODERNATX, INC.-MOD-2023-715806:
Patient's throat closed for a few seconds and opened back up during booster shot; This spontaneous case was reported by a pharmacist and describes the occurrence of THROAT TIGHTNESS (Patient's throat closed for a few seconds and opened back up during booster shot) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROAT TIGHTNESS (Patient's throat closed for a few seconds and opened back up during booster shot). At the time of the report, THROAT TIGHTNESS (Patient's throat closed for a few seconds and opened back up during booster shot) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.No concomitant medications were reported.No treatment medications were reported. This case was linked to MOD-2021-388922 (Patient Link).
This spontaneous report as received from a physician refers to a 12 year old female patient. On 06-AUG-2013, the patient was inadvertently vaccinated with a single dose of GARDASIL (Lot # H021346, expiration date 01-OCT-2015) intramuscularly after the patient had received three doses of CERVARIX. The physician stated that this was an other than indicated use of GARDASIL. It was also reported that the patient had an unspecified reaction after receiving the third dose of CERVARIX. The patient did not have a reaction to GARDASIL. Additional information has been requested.
VARIVAX vaccine was administered following a ssupported temperature excursion; This spontaneous report was received from a health care business professional, a chief executive officer, referring to a 4 year old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 13-SEP-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot# T038830, expiration date on 17-NOV-2022, for prophylaxis following a supported temperature excursion (on 28-JUN-2021). Temperature: 8.4 °F, time frame: 1 hour 30 minutes and 0 seconds, there was no previous temperature excursion.
After the required wait period of 15 minutes I started to drive back home which is 77 miles from the hospital that administered the vaccination.  Around 15 minutes down the road I started feeling like something was caught in my throat and was coughing a little.  At that time I decided to turn around and go back to the hospital.  I took an oral Benadryl 25mg and decided to wait in my car and see if it was something else.  After 30-45 minutes I took a drink of water and realized I was having trouble swallowing.  I then preceded into the ER and was admitted immediately.    In the ER, they started an IV, administered Benadryl, methylprednisolone and a bag of saline.  The physician discussed with me and we agreed to hold the Epinephrine to see how I reacted to the previous medications.  I was then monitored for a couple hours then released with a prescription of Prednisone 60mg for 5 days and an EpiPen.    One day out, no new symptoms besides injection site pain.
gotten two doses of Pfizer-BioNTech COVID-19 Vaccine and a booster shot/thought that she tested positive; gotten two doses of Pfizer-BioNTech COVID-19 Vaccine and a booster shot/thought that she tested positive; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SUSPECTED COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "gotten two doses of Pfizer-BioNTech COVID-19 Vaccine and a booster shot/thought that she tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive. Caller stated that that she has gotten two doses of  Pfizer-BioNTech COVID-19 Vaccine and a booster shot ,recently came in contact with Covid and thought that she tested positive because per caller she "freak  out and threw the test in the garbage "caller stated" I have no symptoms"  wanted to  know if she needed to quarantine. Stated that she was wearing a mask in public.  Follow-up attempts are completed. No further information is expected.
Fever 103.6, shaking chill, headache, sore throat, dizziness/off balance, severe body aches and joint pain with burning at large joints, weakness, stuffiness, heavy head feeling  and inability to keep thoughts?.  All resolved in 48 hours except mild dizziness, thought disruption, head heaviness and mild muscle and joint aches - still present now on 11/3?.    Shot number two had similar symptoms but much worse lasting a full week or more.
Sudden onset Acute UTI- (I have only EVER had a UTI once before 25 year ago and unsure if it was immediately after flu vaccine)- First symptom feeling like I had to urinate frequently following shortly by pain to urethra area, constant feeling of having to urinate but passing very little urine each time -then by 9:00 pm, had pinkish blood stains when wiping- noticeable bloody urine and passing blood clots in urine by 10 pm.